Back

Experimental evidence on colchicine's mode of action in human carotid artery plaques

1 September 2024 (14:50 - 15:00)
Organised by: Logo
Congress Presentation Part of: Novel drugs for cardiovascular diseases Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ines Derya Steenbuck

Heart Center, University of Freiburg, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
Zibotentan in microvascular angina: a randomized, placebo-controlled, crossover trial
Doctor A. Morrow (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Inhibition of ceramide de novo synthesis mitigates atherosclerosis
Miss S. Chong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
The short-term prognosis of salvianolate use during hospitalization in patients with acute myocardial infarction
Doctor R. Guo (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Safety, tolerability, and basic pharmacokinetic parameters of AUX-001, a once-daily extended release nicorandil in healthy volunteers under fasting and fed conditions
Doctor U. Tigoer (Saratoga Springs, US)
Abstract Slides Video
Presentation thumbnail
SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study
Mr C. Lv (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Novel drugs for cardiovascular diseases
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 14:50 CET
You may be interested in
thumbnail
Congress Presentation
Highlights from the study on colchicine for secondary prevention of stroke and other cardiovascular events
thumbnail
Congress Presentation
Anti-inflammatory treatment for coronary artery disease
thumbnail
Congress Session
Novel drugs for cardiovascular diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources